Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2025 ,inter alia, to consider and approve 1. consider and approve and take on record the Standalone and Consolidated Audited Financial Results of the Company for the quarter and financial year ended 31 March 2025;\r\n\r\n2. consider and recommend a final dividend, if any, on the equity shares of the Company for the financial year ended 31 March 2025, subject to approval of the shareholders at the ensuing Annual General Meeting of the Company.\r\n\r\nFurther, in accordance with the Company's Code of Conduct for Prohibition of Insider Trading, the Company has intimated its ''designated persons'' regarding the closure of the Trading Window for trading in the Company's equity shares from 01 April 2025 till the expiry of 48 hours from the date the said financial results are made public.